Luke D. Mascarenhas

ORCID: 0000-0003-1540-5732
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Computational Drug Discovery Methods
  • Neurological Disorders and Treatments
  • Phosphodiesterase function and regulation
  • Synthesis and biological activity
  • Bone Tumor Diagnosis and Treatments
  • Spine and Intervertebral Disc Pathology
  • Pelvic and Acetabular Injuries
  • Synthesis and Reactions of Organic Compounds
  • Scoliosis diagnosis and treatment
  • Inflammatory mediators and NSAID effects
  • Cardiac tumors and thrombi
  • Enzyme function and inhibition
  • Sarcoma Diagnosis and Treatment
  • Vitamin K Research Studies
  • Protein Kinase Regulation and GTPase Signaling

Baylor Scott & White Medical Center - Temple
2024

The University of Texas Southwestern Medical Center
2019-2023

Baylor University Medical Center
2022

Southwestern Medical Center
2019-2021

The Concise Guide to PHARMACOLOGY 2021/22 is the fifth in this series of biennial publications. provides concise overviews, mostly tabular format, key properties nearly 1900 human drug targets with an emphasis on selective pharmacology (where available), plus links open access knowledgebase source and their ligands (www.guidetopharmacology.org), which more detailed views target ligand properties. Although constitutes over 500 pages, material presented substantially reduced compared...

10.1111/bph.15537 article EN cc-by British Journal of Pharmacology 2021-09-16

The Concise Guide to PHARMACOLOGY 2023/24 is the sixth in this series of biennial publications. provides concise overviews, mostly tabular format, key properties approximately 1800 drug targets, and about 6000 interactions with 3900 ligands. There an emphasis on selective pharmacology (where available), plus links open access knowledgebase source targets their ligands ( www.guidetopharmacology.org ), which more detailed views target ligand properties. Although constitutes almost 500 pages,...

10.1111/bph.16176 article EN cc-by British Journal of Pharmacology 2023-10-01

Synovial sarcoma, a rare soft tissue malignancy, predominantly affects adolescents and young adults, with predilection for extremities. We present the case of 19-year-old woman rapidly growing left shoulder synovial initially managed neoadjuvant chemotherapy to reduce tumor size. Subsequently, she underwent radical surgical resection, necessitating complex anatomical dissection due involvement extending into coracoid deltoid. Given limitations in current literature regarding reconstructive...

10.1080/08998280.2024.2435777 article EN Baylor University Medical Center Proceedings 2024-12-18

Regulator of G protein Signaling, or RGS, proteins serve an important regulatory role in signaling mediated by protein-coupled receptors (GPCRs). They all share a common RGS domain that directly interacts with active, GTP-bound Gα subunits heterotrimeric proteins. stabilize the transition state for GTP hydrolysis on and thus induce conformational change subunit accelerates hydrolysis, thereby effectively turning off cascades GPCRs. This GTPase accelerating (GAP) activity is canonical...

10.2218/gtopdb/f891/2021.2 article EN IUPHAR/BPS Guide to Pharmacology CITE 2021-06-25

Regulators of G protein signalling (RGS) proteins display a common RGS domain that interacts with the GTP-bound Gα subunits heterotrimeric proteins, enhancing GTP hydrolysis by stabilising transition state [29, 419, 418], leading to termination GPCR signalling. Interactions through protein:protein interactions many have been identified for targets other than heteromeric proteins. Sequence analysis 20 suggests four families RGS: RZ, R4, R7 and R12 families. Many these effects targetting...

10.2218/gtopdb/f891/2019.4 article EN IUPHAR/BPS Guide to Pharmacology CITE 2019-09-16

Regulator of G protein Signaling, or RGS, proteins serve an important regulatory role in signaling mediated by protein-coupled receptors (GPCRs). They all share a common RGS domain that directly interacts with active, GTP-bound Gα subunits heterotrimeric proteins. stabilize the transition state for GTP hydrolysis on and thus induce conformational change subunit accelerates hydrolysis, thereby effectively turning off cascades GPCRs. This GTPase accelerating (GAP) activity is canonical...

10.2218/gtopdb/f891/2020.4 article EN IUPHAR/BPS Guide to Pharmacology CITE 2020-09-24

Regulator of G protein Signaling, or RGS, proteins serve an important regulatory role in signaling mediated by protein-coupled receptors (GPCRs). They all share a common RGS domain that directly interacts with active, GTP-bound Gα subunits heterotrimeric proteins. stabilize the transition state for GTP hydrolysis on and thus induce conformational change subunit accelerates hydrolysis, thereby effectively turning off cascades GPCRs. This GTPase accelerating (GAP) activity is canonical...

10.2218/gtopdb/f891/2020.5 article EN IUPHAR/BPS Guide to Pharmacology CITE 2020-11-12
Coming Soon ...